Brian Leaf

Partner
Full contact info

Experience

Super Group Completes Warrant Exchange Offer and Consent Solicitation

January 10, 2023

Cooley advised Super Group, the holding company for top global online sports betting and gaming businesses Betway and Spin, on the completion of its public warrant exchange offer and warrant consent solicitation, as well as its related earnout shares waiver. Jointly, the measures removed the potential issuance of approximately 78.8 million of Super Group’s ordinary shares, lowering Super Group’s potential fully diluted share count by 13.6%. The exchange offer and consent solicitation simplified Super Group’s capital structure, increased its public float and reduced the potentially dilutive impact of the warrants.

Related contacts

Justin Stock
Managing Partner – London, London
David Boles
Partner, London
Brian Leaf
Partner, Reston
Rita Sobral
Associate, London
Kyle Huh
Associate, Palo Alto
Harry Calkin
Associate, London
Aaron Pomeroy
Partner, Colorado
Xander Lee
Partner, Los Angeles Santa Monica
Rick Jantz
Associate, Los Angeles Santa Monica

Related Practices & Industries

MaxCyte – $202 Million IPO

July 30, 2021

Cooley advised MaxCyte on its $201.8 million initial public offering of 15,525,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. MaxCyte, whose securities now trade on the Nasdaq Global Select Market under the symbol “MXCT,” also trades on the London Stock Exchange under the symbols "MXCT" and "MXCN." MaxCyte is a leading provider of cell-engineering platform technologies. Partners Christian Plaza, Brian Leaf and Claire Keast-Butler led the Cooley team.

Related contacts

Christian Plaza
Partner, Reston
Brian Leaf
Partner, Reston
Claire Keast-Butler
Partner, London
Katie Kazem
Partner, Reston
Paul Alexander
Associate, Washington DC
Moussa O. Ismail
Associate, Reston
Charles George
Associate, London
Div Gupta
Partner, New York
Brent Siler
Senior Counsel, Washington DC
Madison Jones
Partner, Washington DC
Denny Xu
Associate, Boston

Related Practices & Industries

Elevation Oncology – $107 Million IPO

June 25, 2021

Cooley advised the underwriters on Elevation Oncology’s $106.5 million initial public offering of 6,653,407 shares of common stock. J.P. Morgan Securities, Cowen and Company, and SVB Leerink acted as joint bookrunning managers for the offering. Wedbush PacGrow acted as lead manager for the offering. Elevation Oncology, whose securities now trade on the Nasdaq Global Select Market under the symbol ELEV, is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers. Partners Charlie Kim, Brian Leaf and Div Gupta led the Cooley team.

Related contacts

Charlie Kim
Partner, San Diego
Brian Leaf
Partner, Reston
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York

Related Practices & Industries

IronNet Agrees to SPAC Merger With LGL Systems Acquisition Corporation

March 16, 2021

Cooley advised IronNet on its agreement to combine with LGL Systems Acquisition Corp., a publicly traded special purpose acquisition company or SPAC - a transaction with an equity value of $874 million. The combined company will remain publicly listed on the NYSE under the symbol "IRNT". Partners Garth Osterman, Brian Leaf and Brooke Nussbaum led the Cooley team advising IronNet.

Read more

Related contacts

Garth Angelo Osterman
Partner, San Francisco
Edward Sniezek
Associate, Reston
Brian Leaf
Partner, Reston
Brooke Nussbaum
Partner, Washington DC
David Walsh
Partner, Reston
Eileen Marshall
Partner, Washington DC
David Dalton
Associate, Los Angeles Santa Monica

Related Practices & Industries

AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value

February 17, 2021

Cooley advised AvePoint, the largest data management solutions provider for the Microsoft cloud, on its agreement to combine with Apex Technology Acquisition Corporation, a publicly traded special purpose acquisition company or SPAC. Partners David Silverman, John McKenna and Brian Leaf led the Cooley team advising AvePoint.

Read more

Related contacts

David Silverman
Partner, New York
John McKenna
Partner, Palo Alto
Brian Leaf
Partner, Reston
David Walsh
Partner, Reston
Mike Lincoln
Vice Chair, Reston
Eileen Marshall
Partner, Washington DC
Stephanie Gentile
Partner, New York
Thomas Connors
Partner, Boston
Stella Sarma
Special Counsel, Brussels
Karen Tsai
Special Counsel, Washington DC
Benjamin “Izzy” Lubarsky
Associate, New York
Katie Kazem
Partner, Reston
Mary Maher Lewis
Special Counsel, Reston
Alex Fagella
Associate, New York
Carly Mitchell
Associate, Washington DC
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

View more

Memberships & affiliations

American Bar Association

American Institute of Certified Public Accountants